Steve Lo

Currently holds a position at Zosano Pharma Corp

1.5

1.5

Position	Company	Period
Chief Executive Officer, Director	Zosano Pharma Corp	Oct. 21, 2019 -
Chief Commercial Officer	Puma Biotechnology Inc	Sept. 1, 2015 - Oct. 18, 2019
Senior Vice President, Oncology	Corcept Therapeutics Inc	Feb. 1, 2015 - Sept. 4, 2015
Senior Vice President, Chief Commercial Officer	Corcept Therapeutics Inc	Nov. 19, 2013 - Feb. 1, 2015
Vice President - Commercial Operations	Corcept Therapeutics Inc	Sept. 16, 2010 - Nov. 19, 2013

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value
2025-05-19	2025-05-19	Vaxart Inc (VXRT)	B Purchase	80,290 +5.8% 67.11 US$3,034,262	80,290 +5.8%	67.11	US$3,034,262
2022-06-07	2022-06-06	Zosano Pharma Corp (ZSAN)	S Sale	60,795 -26.6% 432.88 US$3,915,891	60,795 -26.6%	432.88	US$3,915,891
2022-04-01	2022-03-31	Zosano Pharma Corp (ZSAN)	S Sale	67,129 +10.0% 328.97 US$2,002,785	67,129 +10.0%	328.97	US$2,002,785
2019-07-24	2019-07-22	Puma Biotechnology Inc (PBYI)	PlS Planned sale	1,852 -8.7% 10.04 US$18,600	1,852 -8.7%	10.04	US$18,600
2019-01-24	2019-01-22	Puma Biotechnology Inc (PBYI)	PlS Planned sale	2,114 -9.0% 24.91 US$52,664	2,114 -9.0%	24.91	US$52,664
2018-07-24	2018-07-20	Puma Biotechnology Inc (PBYI)	PlS Planned sale	1,839 -7.3% 51.85 US$95,360	1,839 -7.3%	51.85	US$95,360
2018-01-24	2018-01-22	Puma Biotechnology Inc (PBYI)	PlS Planned sale	1,858 -6.8% 92.85 US$172,515	1,858 -6.8%	92.85	US$172,515
2017-07-24	2017-07-20	Puma Biotechnology Inc (PBYI)	PlS Planned sale	1,990 -6.8% 94.90 US$188,853	1,990 -6.8%	94.90	US$188,853
2017-01-24	2017-01-20	Puma Biotechnology Inc (PBYI)	PlS Planned sale	2,290 -7.3% 33.24 US$76,108	2,290 -7.3%	33.24	US$76,108